ArriVent BioPharma Inc Sustainability Reports
ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on identifying, licensing, and developing novel targeted therapies for cancer patients with unmet medical needs.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG011N37VW3
1 reports from 2024 to 2024
Company Profile
ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on identifying, licensing, and developing novel targeted therapies for cancer patients with unmet medical needs.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
